Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents

B. A M Sanchez, Maria M. Mota, Ali Sultan, Luzia H. Carvalho

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

High priority has been given to new assays that facilitate and accelerate the development of novel antimalarial compounds. Unlike evaluation of drugs in vitro, in which new approaches have been used to expedite identification of parasites, the conventional in vivo murine assay requires determination of parasitemia by light microscopy, an incompatible technique to test large numbers of drugs. We have investigated the possibility of using an autonomously fluorescent Plasmodium berghei strain, stably transformed with the green fluorescent protein, to rapidly quantify parasite growth by flow cytometry. The major improvement of this method is that P. berghei line transformed with green fluorescent protein parasites can be quickly and specifically detected in a drop of parasite-infected blood without any manipulation of the sample. Our results showed a clear correlation between the numbers of fluorescent cells detected by flow cytometry and conventional parasitemia, including a correspondence in the peaks of parasitemia. The validation of P. berghei line transformed with green fluorescent protein for chemotherapy studies was performed by evaluating its response to conventional antimalarial drugs such as chloroquine, quinine and sodium artesunate. The results of drug-susceptibility assays as determined by flow cytometry were comparable with those obtained by microscopic examination of Giemsa-stained slides. This PbGFP parasite should prove to be a rapid, simple and sensitive tool for the examination of the large number of compounds and conditions involved in the initial stages of drug development.

Original languageEnglish
Pages (from-to)485-490
Number of pages6
JournalInternational Journal for Parasitology
Volume34
Issue number4
DOIs
Publication statusPublished - 29 Mar 2004
Externally publishedYes

Fingerprint

Plasmodium berghei
Green Fluorescent Proteins
Parasites
Parasitemia
Flow Cytometry
Antimalarials
Pharmaceutical Preparations
Drug Evaluation
Quinine
Chloroquine
Microscopy
Cell Count
Light
Drug Therapy
Growth

Keywords

  • Chemotherapy
  • Flow cytometry
  • Green fluorescent protein
  • Plasmodium berghei

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases

Cite this

Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents. / Sanchez, B. A M; Mota, Maria M.; Sultan, Ali; Carvalho, Luzia H.

In: International Journal for Parasitology, Vol. 34, No. 4, 29.03.2004, p. 485-490.

Research output: Contribution to journalArticle

@article{bdcda338e34c48dd8d8c20ae6d8ad8f2,
title = "Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents",
abstract = "High priority has been given to new assays that facilitate and accelerate the development of novel antimalarial compounds. Unlike evaluation of drugs in vitro, in which new approaches have been used to expedite identification of parasites, the conventional in vivo murine assay requires determination of parasitemia by light microscopy, an incompatible technique to test large numbers of drugs. We have investigated the possibility of using an autonomously fluorescent Plasmodium berghei strain, stably transformed with the green fluorescent protein, to rapidly quantify parasite growth by flow cytometry. The major improvement of this method is that P. berghei line transformed with green fluorescent protein parasites can be quickly and specifically detected in a drop of parasite-infected blood without any manipulation of the sample. Our results showed a clear correlation between the numbers of fluorescent cells detected by flow cytometry and conventional parasitemia, including a correspondence in the peaks of parasitemia. The validation of P. berghei line transformed with green fluorescent protein for chemotherapy studies was performed by evaluating its response to conventional antimalarial drugs such as chloroquine, quinine and sodium artesunate. The results of drug-susceptibility assays as determined by flow cytometry were comparable with those obtained by microscopic examination of Giemsa-stained slides. This PbGFP parasite should prove to be a rapid, simple and sensitive tool for the examination of the large number of compounds and conditions involved in the initial stages of drug development.",
keywords = "Chemotherapy, Flow cytometry, Green fluorescent protein, Plasmodium berghei",
author = "Sanchez, {B. A M} and Mota, {Maria M.} and Ali Sultan and Carvalho, {Luzia H.}",
year = "2004",
month = "3",
day = "29",
doi = "10.1016/j.ijpara.2003.11.011",
language = "English",
volume = "34",
pages = "485--490",
journal = "International Journal for Parasitology",
issn = "0020-7519",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents

AU - Sanchez, B. A M

AU - Mota, Maria M.

AU - Sultan, Ali

AU - Carvalho, Luzia H.

PY - 2004/3/29

Y1 - 2004/3/29

N2 - High priority has been given to new assays that facilitate and accelerate the development of novel antimalarial compounds. Unlike evaluation of drugs in vitro, in which new approaches have been used to expedite identification of parasites, the conventional in vivo murine assay requires determination of parasitemia by light microscopy, an incompatible technique to test large numbers of drugs. We have investigated the possibility of using an autonomously fluorescent Plasmodium berghei strain, stably transformed with the green fluorescent protein, to rapidly quantify parasite growth by flow cytometry. The major improvement of this method is that P. berghei line transformed with green fluorescent protein parasites can be quickly and specifically detected in a drop of parasite-infected blood without any manipulation of the sample. Our results showed a clear correlation between the numbers of fluorescent cells detected by flow cytometry and conventional parasitemia, including a correspondence in the peaks of parasitemia. The validation of P. berghei line transformed with green fluorescent protein for chemotherapy studies was performed by evaluating its response to conventional antimalarial drugs such as chloroquine, quinine and sodium artesunate. The results of drug-susceptibility assays as determined by flow cytometry were comparable with those obtained by microscopic examination of Giemsa-stained slides. This PbGFP parasite should prove to be a rapid, simple and sensitive tool for the examination of the large number of compounds and conditions involved in the initial stages of drug development.

AB - High priority has been given to new assays that facilitate and accelerate the development of novel antimalarial compounds. Unlike evaluation of drugs in vitro, in which new approaches have been used to expedite identification of parasites, the conventional in vivo murine assay requires determination of parasitemia by light microscopy, an incompatible technique to test large numbers of drugs. We have investigated the possibility of using an autonomously fluorescent Plasmodium berghei strain, stably transformed with the green fluorescent protein, to rapidly quantify parasite growth by flow cytometry. The major improvement of this method is that P. berghei line transformed with green fluorescent protein parasites can be quickly and specifically detected in a drop of parasite-infected blood without any manipulation of the sample. Our results showed a clear correlation between the numbers of fluorescent cells detected by flow cytometry and conventional parasitemia, including a correspondence in the peaks of parasitemia. The validation of P. berghei line transformed with green fluorescent protein for chemotherapy studies was performed by evaluating its response to conventional antimalarial drugs such as chloroquine, quinine and sodium artesunate. The results of drug-susceptibility assays as determined by flow cytometry were comparable with those obtained by microscopic examination of Giemsa-stained slides. This PbGFP parasite should prove to be a rapid, simple and sensitive tool for the examination of the large number of compounds and conditions involved in the initial stages of drug development.

KW - Chemotherapy

KW - Flow cytometry

KW - Green fluorescent protein

KW - Plasmodium berghei

UR - http://www.scopus.com/inward/record.url?scp=1542358694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542358694&partnerID=8YFLogxK

U2 - 10.1016/j.ijpara.2003.11.011

DO - 10.1016/j.ijpara.2003.11.011

M3 - Article

C2 - 15013738

AN - SCOPUS:1542358694

VL - 34

SP - 485

EP - 490

JO - International Journal for Parasitology

JF - International Journal for Parasitology

SN - 0020-7519

IS - 4

ER -